29 Results for "

Activin A Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (29)

29 Results for "Activin A Inhibitors" in MCE Product Catalog:

22
22 Publications Verification
Cat. No.: HY-13012
CAS No.: 446859-33-2
Purity:  99.92%
Synonyms: E-616452; SJN 2511
Research Areas:  

Metabolic Disease

RepSox (E-616452) is a potent and selective transforming growth factor-beta receptor I/activin like kinase 5 (TGF-β-RI/ALK5) inhibitor. RepSox inhibits ALK5 autophosphorylation with an IC50 value of 4 nM. RepSox can be used for the research of obesity and associated metabolic diseases such as type 2 diabetes .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10326
CAS No.: 452342-67-5
Purity:  99.92%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, and also inhibits TGF-β type II receptor and activin type II receptor activities, without inhibiting BMP type II receptor.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928
CAS No.: 1352608-82-2
Synonyms: EW-7197; TEW-7197
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib (EW-7197) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib has potently antimetastatic activity and anticancer effect .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928A
CAS No.: 1352610-25-3
Synonyms: EW-7197 Hydrochloride; TEW-7197 Hydrochloride
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib Hydrochloride also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib Hydrochloride has potently antimetastatic activity and anticancer effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-78349
CAS No.: 607737-87-1
Target:  

TGF-β Receptor

Research Areas:  

Cancer

A 77-01 is a potent inhibitor of transforming growth factor (TGF)-β type I receptor superfamily activin-like kinase ALK5 with an IC50 of 25 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99632
CAS No.: 2097125-54-5
Synonyms: REGN 2477

Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology

Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99590A
Synonyms: RAP-011
Sotatercept (mIgG2a) (RAP-011), the murine homolog of Sotatercept (ACE-011) (HY-P99590), is a soluble activin receptor type IIA (ActRIIA) ligand trap. Sotatercept (mIgG2a) inhibits the binding of activin A and other members of the TGF-β superfamily (such as Activin A/B, GDF11 and BMP9/10) to their receptors by combining and neutralizing them, thereby regulating cell proliferation and differentiation. Sotatercept (mIgG2a) mainly inhibits the SMAD2/3 signaling pathway, and can be used in various diseases such as chronic kidney disease. Sotatercept (mIgG2a) reduces the expression of erythropoietic hepcidin (ERFE), regulates iron metabolism, and promotes red blood cell production. Sotatercept (mIgG2a) has a dual effect of promoting bone formation (anabolic) and inhibiting bone resorption (catabolic) .
loading...
    loading...
Cat. No.: HY-117887
CAS No.: 2141955-96-4
Synonyms: BLU-782; IPN-60130; ALK2-IN-1
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Fidrisertib (BLU-782) is the orally active inhibitor for activin receptor-like kinase 2 (ALK2) that inhibits ALK2 R206H, ALK2, ALK1, ALK6, ALK3, ALK4, TGFβR2 and ALK5 with IC50s of 0.2, 0.6, 3, 24, 45, 65, 67 and 155 nM, respectively .
loading...
    loading...
Cat. No.: HY-136773
CAS No.: 2248154-85-8
Purity:  99.35%
Synonyms: ALK2-IN-4
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 (ALK2-IN-4) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...
Cat. No.: HY-P99818
CAS No.: 1169766-01-1
Synonyms: ACE-031

Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

Ramatercept (ACE-031) is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy .
loading...
    loading...
Cat. No.: HY-151289
CAS No.: 2785430-90-0
Purity:  98.21%
Research Areas:  

Cancer

ALK5-IN-34 is an selective orally active activin receptor-like kinase (ALK) inhibitor. ALK5-IN-34 can inhibit the activity of ALK5-IN-34 with an IC50 value of ≤10 nM. ALK5-IN-34 also has inhibitory of tumor growth and can be used for the research of proliferative diseases, such as cancer .
loading...
    loading...
Cat. No.: HY-125851
CAS No.: 1976038-41-1
Purity:  99.42%
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology

TP-008, a chemical probe, is a potent, selective and orally active (Activin-Like Kinase 5) ALK5 inhibitor with pIC50 and pEC50 values of 7.6 and 6.63, respectively. TGFβRI-IN-2 can produce observed cardiac toxicity in vivo at high dose .
loading...
    loading...
Cat. No.: HY-173149
CAS No.: 3052084-77-9
CDD-2789 is a potent and selective ALK2 inhibitor with an IC50 0.54 μM and a Kd of 2.1 nM, respectively. CDD-2789 exhibits >120-fold selectivity over ALK3/5/6. CDD-2789 reduces activin A- and BMP2-induced SMAD1/5 phosphorylation in fibroblasts. CDD-2789 can be used for ALK2-related cancer research .
loading...
    loading...
Cat. No.: HY-155939
CAS No.: 2863635-04-3
Purity:  98.30%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2163 dihydrochloride is a potent, selective, blood-brain barrier (BBB) permeable activin receptor-like kinase-2 (ALK2) inhibitor, with an IC50 of 19 nM. M4K2163 dihydrochloride can be used in the research of diffuse intrinsic pontine glioma (DIPG) .
loading...
    loading...
Cat. No.: HY-P990720
CAS No.: 2727114-26-1
Synonyms: KER-050

Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

Elritercept (KER-050) is a recombinant fusion protein comprising a modified activin receptor type IIA extracellular domain fused to a human IgG1 Fc. Elritercept inhibits activin A and other select TGF-β superfamily ligands .
loading...
    loading...
Cat. No.: HY-13012R
CAS No.: 446859-33-2
Synonyms: E-616452 (Standard); SJN 2511 (Standard)
RepSox (Standard) is the analytical standard of RepSox. This product is intended for research and analytical applications. RepSox (E-616452) is a potent and selective transforming growth factor-beta receptor I/activin like kinase 5 (TGF-β-RI/ALK5) inhibitor. RepSox inhibits ALK5 autophosphorylation with an IC50 value of 4 nM. RepSox can be used for the research of obesity and associated metabolic diseases such as type 2 diabetes .
loading...
    loading...
Cat. No.: HY-122179
CAS No.: 1060469-90-0
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology

NUCC-555 is an activin antagonist. NUCC-555 interacts with Trp25, Trp28, Phe55, Tyr93, Lys103, and Asn107 in the Activin A binding pocket. NUCC-555 blocks Activin A-mediated hepatic stellate cells (HSCs) activation. NUCC-555 promotes liver regeneration and halts fibrosis progression in chronic liver disease models. NUCC-555 inhibits Activin A-mediated ovarian cell proliferation. NUCC-555 decreases FSH levels in ovariectomized mice .
loading...
    loading...
Cat. No.: HY-149403
CAS No.: 2374772-60-6
Research Areas:  

Others

J-1048 is an activin receptor-like kinase 5 (ALK5) inhibitor. J-1048 can inhibit TAA-induced liver fibrosis in mice by explicitly blocking the TGF-β/Smad signaling pathway .
loading...
    loading...
Cat. No.: HY-161377
CAS No.: 3034840-25-7
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2306 is a selective inhibitor for activin receptor-like kinase-2 (ALK2) with an IC50 of 7 nM. M4K2306 is blood brain permeable with a brain to plasma ratio of 75.6 .
loading...
    loading...
Cat. No.: HY-151272
CAS No.: 2785430-82-0
Research Areas:  

Cancer

ALK5-IN-26 (EX-22) is an ALK (Activin receptor-like kinase) inhibitor. ALK5-IN-26 inhibits ALK5 with an IC50 value ≤10 nM. ALK5-IN-26 can be used for the research of cancer .
loading...
    loading...